Pathophysiological differences between atrial fibrillation subgoups: Is there a fibrillatory-induced atherosclerotic disease progression?

por Goette, Andreas
Publicado 2021

Atrial fibrillation patients undergoing percutaneous coronary intervention: dual or triple antithrombotic therapy with non-vitamin K antagonist oral anticoagulants

por Goette, Andreas, Vranckx, Pascal
Publicado 2020

Ten years of non-vitamin K antagonists oral anticoagulants for stroke prevention in atrial fibrillation: is warfarin obsolete?

por Hammwöhner, Matthias, Goette, Andreas
Publicado 2020

Infections of cardiac implantable electronic devices: still a cause of high mortality

por Goette, Andreas, Sommer, Philipp
Publicado 2021

Atrial Cardiomyopathy: Pathophysiology and Clinical Consequences

por Goette, Andreas, Lendeckel, Uwe
Publicado 2021

Higher risk of stent thrombosis with double therapy with direct oral anticoagulants: cherry picking the populations of interest does not help

por Gargiulo, Giuseppe, Goette, Andreas, Vranckx, Pascal, Valgimigli, Marco
Publicado 2020

COVID-19-Induced Cytokine Release Syndrome Associated with Pulmonary Vein Thromboses, Atrial Cardiomyopathy, and Arterial Intima Inflammation

por Goette, Andreas, Patscheke, Markus, Henschke, Frank, Hammwöhner, Matthias
Publicado 2020

Oxidative Stress and Microcirculatory Flow Abnormalities in the Ventricles during Atrial Fibrillation

por Goette, Andreas, Bukowska, Alicja, Lillig, Christopher H., Lendeckel, Uwe
Publicado 2012

Psychological aspects of atrial fibrillation: A systematic narrative review: Impact on incidence, cognition, prognosis, and symptom perception

por Ladwig, Karl-Heinz, Goette, Andreas, Atasoy, Seryan, Johar, Hamimatunnisa
Publicado 2020

Covid-19 pandemic induced traumatizing medical job contents and mental health distortions of physicians working in private practices and in hospitals

por Ladwig, Karl-Heinz, Johar, Hamimatunnisa, Miller, Inna, Atasoy, Seryan, Goette, Andreas
Publicado 2023

Twenty-five years in the making: flecainide is safe and effective for the management of atrial fibrillation

por Aliot, Etienne, Capucci, Alessandro, Crijns, Harry J., Goette, Andreas, Tamargo, Juan
Publicado 2011

Successful catheter ablation of a left posterolateral accessory bypass tract and periinterventional management in a patient with MELAS syndrome

por Goette, Andreas, Brandner, Sybille, Wojcik, Michal Jakub, Berger, Christian, Hammwöhner, Matthias
Publicado 2022

Pleiotropic effects of NOACs with focus on edoxaban: scientific findings and potential clinical implications

por Goette, Andreas, Mollenhauer, Martin, Rudolph, Volker, Lamparter, Mathias, Meier, Martin, Böhm, Michael
Publicado 2023

Edoxaban in patients with non-valvular atrial fibrillation after percutaneous coronary intervention: ENCOURAGE-AF design

por Baldus, Stephan, Beyer-Westendorf, Jan, Möllmann, Helge, Rottbauer, Wolfgang, Beyerlein, Elisabeth, Goette, Andreas
Publicado 2023

Thrombotisch-thrombozytopenische Purpura – eine differenzialdiagnostische Herausforderung im Notfall

por Özcan, Fedai, Köhrmann, Martin, Petros, Sirak, Goette, Andreas, Bramlage, Peter, Bommer, Martin, Brokmann, Jörg Christian
Publicado 2023

One-year safety and quality of life outcomes in patients with atrial fibrillation on dronedarone: prospective, non-interventional study in German ambulatory care

por Goette, Andreas, Benninger, G., Pittrow, D., Paar, W.D., von Stritzky, B., Bosch, R.F.
Publicado 2015

Edoxaban therapy increases treatment satisfaction and reduces utilization of healthcare resources: an analysis from the EdoxabaN vs. warfarin in subjectS UndeRgoing cardiovErsion o...

por Goette, Andreas, Kwong, Winghan J, Ezekowitz, Michael D, Banach, Maciej, Hjortshoj, Soren P, Zamoryakhin, Dmitry, Lip, Gregory Y H
Publicado 2018

Atrial high-rate episodes and stroke prevention

por Camm, A. John, Simantirakis, Emmanuel, Goette, Andreas, Lip, Gregory Y.H., Vardas, Panos, Calvert, Melanie, Chlouverakis, Gregory, Diener, Hans-Christoph, Kirchhof, Paulus
Publicado 2017

Clinical risk predictors in atrial fibrillation patients following successful coronary stenting: ENTRUST-AF PCI sub-analysis

por Goette, Andreas, Eckardt, Lars, Valgimigli, Marco, Lewalter, Thorsten, Laeis, Petra, Reimitz, Paul-Egbert, Smolnik, Rüdiger, Zierhut, Wolfgang, Tijssen, Jan G., Vranckx, Pascal
Publicado 2020

Clinical factors related to successful or unsuccessful cardioversion in the EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation (ENSURE‐AF) randomi...

por Lip, Gregory Y. H., Merino, Jose L., Banach, Maciej, Al‐Saady, Naab, Jin, James, Melino, Michael, Winters, Shannon M., Kozieł, Monika, Goette, Andreas
Publicado 2020